Addiction and the itch‐scratch cycle. What do they have in common?
Itch is a multidimensional experience involving various brain regions associated with sensory perception and emotion, as well as an urge to scratch employing the motor system. Scratch temporarily relieves itch sensation in healthy subjects. However, in patients with chronic itch, rather than inhibit...
Saved in:
Published in | Experimental dermatology Vol. 28; no. 12; pp. 1448 - 1454 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Denmark
Wiley Subscription Services, Inc
01.12.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 0906-6705 1600-0625 1600-0625 |
DOI | 10.1111/exd.14029 |
Cover
Abstract | Itch is a multidimensional experience involving various brain regions associated with sensory perception and emotion, as well as an urge to scratch employing the motor system. Scratch temporarily relieves itch sensation in healthy subjects. However, in patients with chronic itch, rather than inhibit, scratch may aggravate itch. Patients with chronic itch, such as those with atopic dermatitis, experience severe itch and a strong desire to scratch. This urge to scratch is the driving force underlying the formation of the itch‐scratch‐cycle, an addictive and vicious cycle in chronic itch patients. This vicious itch‐scratch behaviour and various types of addiction (henceforth, including recreational drug use) were shown to share common sensory mechanisms. Abnormalities have been observed in central neural circuits, including the reward, motivation/drive, control and learning/memory circuits, as well as other brain systems. Reward systems, including the ventral tegmental area (VTA), nucleus accumbens (NAc) and striatum, are important for brain processing of both addiction and itch. In addition to reward, addicted individuals can experience severe disruptions in motor control, cognitive awareness, executive function, learning/memory and even emotional functions. Findings showing that addiction and itch share a common neurobiological foundation could have important mechanistic and therapeutic implications. Here we propose that similar neuroadaptations exist in addiction and chronic itch patients. |
---|---|
AbstractList | Itch is a multidimensional experience involving various brain regions associated with sensory perception and emotion, as well as an urge to scratch employing the motor system. Scratch temporarily relieves itch sensation in healthy subjects. However, in patients with chronic itch, rather than inhibit, scratch may aggravate itch. Patients with chronic itch, such as those with atopic dermatitis, experience severe itch and a strong desire to scratch. This urge to scratch is the driving force underlying the formation of the itch-scratch-cycle, an addictive and vicious cycle in chronic itch patients. This vicious itch-scratch behaviour and various types of addiction (henceforth, including recreational drug use) were shown to share common sensory mechanisms. Abnormalities have been observed in central neural circuits, including the reward, motivation/drive, control and learning/memory circuits, as well as other brain systems. Reward systems, including the ventral tegmental area (VTA), nucleus accumbens (NAc) and striatum, are important for brain processing of both addiction and itch. In addition to reward, addicted individuals can experience severe disruptions in motor control, cognitive awareness, executive function, learning/memory and even emotional functions. Findings showing that addiction and itch share a common neurobiological foundation could have important mechanistic and therapeutic implications. Here we propose that similar neuroadaptations exist in addiction and chronic itch patients. Itch is a multidimensional experience involving various brain regions associated with sensory perception and emotion, as well as an urge to scratch employing the motor system. Scratch temporarily relieves itch sensation in healthy subjects. However, in patients with chronic itch, rather than inhibit, scratch may aggravate itch. Patients with chronic itch, such as those with atopic dermatitis, experience severe itch and a strong desire to scratch. This urge to scratch is the driving force underlying the formation of the itch-scratch-cycle, an addictive and vicious cycle in chronic itch patients. This vicious itch-scratch behaviour and various types of addiction (henceforth, including recreational drug use) were shown to share common sensory mechanisms. Abnormalities have been observed in central neural circuits, including the reward, motivation/drive, control and learning/memory circuits, as well as other brain systems. Reward systems, including the ventral tegmental area (VTA), nucleus accumbens (NAc) and striatum, are important for brain processing of both addiction and itch. In addition to reward, addicted individuals can experience severe disruptions in motor control, cognitive awareness, executive function, learning/memory and even emotional functions. Findings showing that addiction and itch share a common neurobiological foundation could have important mechanistic and therapeutic implications. Here we propose that similar neuroadaptations exist in addiction and chronic itch patients.Itch is a multidimensional experience involving various brain regions associated with sensory perception and emotion, as well as an urge to scratch employing the motor system. Scratch temporarily relieves itch sensation in healthy subjects. However, in patients with chronic itch, rather than inhibit, scratch may aggravate itch. Patients with chronic itch, such as those with atopic dermatitis, experience severe itch and a strong desire to scratch. This urge to scratch is the driving force underlying the formation of the itch-scratch-cycle, an addictive and vicious cycle in chronic itch patients. This vicious itch-scratch behaviour and various types of addiction (henceforth, including recreational drug use) were shown to share common sensory mechanisms. Abnormalities have been observed in central neural circuits, including the reward, motivation/drive, control and learning/memory circuits, as well as other brain systems. Reward systems, including the ventral tegmental area (VTA), nucleus accumbens (NAc) and striatum, are important for brain processing of both addiction and itch. In addition to reward, addicted individuals can experience severe disruptions in motor control, cognitive awareness, executive function, learning/memory and even emotional functions. Findings showing that addiction and itch share a common neurobiological foundation could have important mechanistic and therapeutic implications. Here we propose that similar neuroadaptations exist in addiction and chronic itch patients. |
Author | Ishiuji, Yozo |
Author_xml | – sequence: 1 givenname: Yozo orcidid: 0000-0002-3941-4011 surname: Ishiuji fullname: Ishiuji, Yozo email: yozoishiuji@gmail.com organization: The Jikei University School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31482585$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kctOwzAQRS1URB-w4AdQJDawSPEribNCVVseUiU2INhZru0oqZK42AmQHZ_AN_IlJLTdVDCbmZHOvRrNHYJeaUoNwCmCY9TWlf5QY0Qhjg_AAIUQ-jDEQQ8MYAxDP4xg0AdD51YQoohEwRHoE0QZDlgwALOJUpmsMlN6olRelWovq2T6_fnlpBXt5MlG5nrsPaei8pTpiMZLxVvLlZ40RWHK62NwmIjc6ZNtH4Gnm_nj9M5fPNzeTycLX5KAxL6SmrIYSsQSGNNui6JlzBCLsEhghDGmFFOhxVIkUuqQQUGkwjJkNIkVQWQELja-a2tea-0qXmRO6jwXpTa14xgzGoQ4Cjr0fA9dmdqW7XUcE8wwDSGJW-psS9XLQiu-tlkhbMN3_2mBqw0grXHO6oTLrBLduyorspwjyLsEeJsA_02gVVzuKXamf7Fb9_cs183_IJ-_zDaKH_L1ky4 |
CitedBy_id | crossref_primary_10_3389_fmed_2023_1101935 crossref_primary_10_1111_exd_14403 crossref_primary_10_1016_j_nlm_2023_107760 crossref_primary_10_1016_j_jaad_2020_08_117 crossref_primary_10_1016_j_alit_2022_04_003 crossref_primary_10_3390_ijms23084140 crossref_primary_10_1186_s13041_024_01101_w crossref_primary_10_1016_j_clindermatol_2025_03_005 crossref_primary_10_1016_j_actpsy_2023_104047 crossref_primary_10_1016_j_jfo_2022_09_009 crossref_primary_10_1155_2024_1494377 crossref_primary_10_3390_ijms21218406 crossref_primary_10_1126_scitranslmed_abn4819 crossref_primary_10_1016_j_anai_2020_11_008 crossref_primary_10_1186_s13020_022_00706_4 crossref_primary_10_1186_s40659_022_00396_0 crossref_primary_10_1016_j_bbrc_2020_11_030 crossref_primary_10_4103_ejdv_ejdv_18_22 crossref_primary_10_1016_j_brainres_2025_149492 crossref_primary_10_1111_exd_14058 crossref_primary_10_3390_jcm12041529 crossref_primary_10_1111_exd_14669 crossref_primary_10_2340_actadv_v103_9403 crossref_primary_10_2340_actadv_v104_35427 crossref_primary_10_3389_fmed_2021_627593 |
Cites_doi | 10.1016/j.cell.2017.08.006 10.1016/j.neuron.2015.11.027 10.3164/jcbn.12-51 10.1038/jid.2015.223 10.31887/DCNS.2017.19.3/gkoob 10.1038/s41586-018-0740-8 10.3389/fpsyt.2018.00095 10.1152/jn.00070.2006 10.1111/ijd.12864 10.3389/fphar.2014.00256 10.1523/JNEUROSCI.2966-07.2007 10.1007/BF00426913 10.1016/S0304-3959(01)00271-8 10.1038/nm.3912 10.1111/j.1529-8019.2008.00166.x 10.1038/nature14188 10.1016/j.nicl.2014.12.002 10.3389/fpsyt.2016.00160 10.1038/s41598-018-19962-2 10.1016/j.neuron.2015.05.044 10.1016/j.neuron.2014.02.046 10.1007/s12016-015-8488-5 10.1016/j.neuropharm.2013.06.030 10.1523/JNEUROSCI.1979-13.2013 10.1016/j.neuron.2014.10.003 10.1152/jn.00827.2013 10.1056/NEJMcp1208814 10.1002/cne.24572 10.1016/j.neubiorev.2018.01.009 10.1111/ejn.13547 10.1523/JNEUROSCI.1267-16.2016 10.1016/j.brainres.2019.03.031 10.1016/j.neulet.2017.08.046 10.1016/j.neuron.2018.08.044 10.1523/JNEUROSCI.1978-13.2015 10.1038/bjp.2008.101 10.1016/j.drugalcdep.2013.02.025 10.1016/j.neures.2016.01.004 10.1038/nn1339 10.1248/bpb.b13-00319 10.1016/j.neuron.2019.03.030 10.2340/00015555-0890 10.1002/ejp.750 10.1016/j.cell.2015.07.046 10.1038/sj.npp.1301438 10.1016/j.jaad.2007.01.007 10.1038/nn1579 10.1016/j.tics.2015.05.005 10.1111/exd.12070 10.1111/j.1365-2133.2012.10826.x 10.1016/0006-8993(92)91327-B 10.1093/ntr/ntr163 10.1016/S0166-2236(03)00233-9 10.1152/jn.00374.2013 10.1523/JNEUROSCI.0143-04.2004 10.1038/npp.2013.261 10.1016/j.conb.2008.07.002 10.1038/jid.2012.52 10.1007/s11920-010-0135-5 10.1016/j.euroneuro.2018.01.007 10.1016/j.neuroimage.2004.08.023 10.1016/S0306-4522(00)00329-8 10.1111/exd.13305 10.1016/j.jaad.2016.02.1237 10.1111/all.12727 10.1038/s41593-018-0119-z 10.1111/all.13065 10.1016/j.jpain.2015.10.008 10.1523/JNEUROSCI.1483-18.2018 10.1177/0269881118764991 10.1016/0165-0173(93)90013-P 10.1016/j.jad.2014.04.055 10.2340/00015555-1353 10.1111/j.1365-2133.2009.09308.x 10.1016/j.jid.2015.12.037 |
ContentType | Journal Article |
Copyright | 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
Copyright_xml | – notice: 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd – notice: 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
DBID | AAYXX CITATION NPM 7T5 H94 K9. NAPCQ 7X8 |
DOI | 10.1111/exd.14029 |
DatabaseName | CrossRef PubMed Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | PubMed CrossRef AIDS and Cancer Research Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1600-0625 |
EndPage | 1454 |
ExternalDocumentID | 31482585 10_1111_exd_14029 EXD14029 |
Genre | article Journal Article |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OB 1OC 29G 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHEFC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 CYRXZ D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH YUY ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION NPM 7T5 AAMMB AEFGJ AGXDD AIDQK AIDYY H94 K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-c3539-dce4890c18f094dce477b981872af072224424aeabafcce680a3cd2c684f9d313 |
IEDL.DBID | DR2 |
ISSN | 0906-6705 1600-0625 |
IngestDate | Fri Jul 11 09:02:29 EDT 2025 Fri Jul 25 09:55:27 EDT 2025 Wed Feb 19 02:32:12 EST 2025 Tue Jul 01 01:14:49 EDT 2025 Thu Apr 24 22:57:22 EDT 2025 Wed Jan 22 16:40:30 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | reward itch vicious cycle dopamine addiction |
Language | English |
License | 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3539-dce4890c18f094dce477b981872af072224424aeabafcce680a3cd2c684f9d313 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0002-3941-4011 |
PMID | 31482585 |
PQID | 2328246039 |
PQPubID | 2045157 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_2284562751 proquest_journals_2328246039 pubmed_primary_31482585 crossref_citationtrail_10_1111_exd_14029 crossref_primary_10_1111_exd_14029 wiley_primary_10_1111_exd_14029_EXD14029 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2019 2019-12-00 2019-Dec 20191201 |
PublicationDateYYYYMMDD | 2019-12-01 |
PublicationDate_xml | – month: 12 year: 2019 text: December 2019 |
PublicationDecade | 2010 |
PublicationPlace | Denmark |
PublicationPlace_xml | – name: Denmark – name: Chichester |
PublicationTitle | Experimental dermatology |
PublicationTitleAlternate | Exp Dermatol |
PublicationYear | 2019 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2015; 35 2010; 12 2001; 92 2012; 166 2013; 22 2015; 70 2016; 108 2018; 564 2004; 7 2004; 23 2004; 24 2017; 45 2016; 75 2011; 13 2019; 527 2008; 33 2016; 71 2013; 17368 2013; 6 2016; 36 2018; 9 2018; 8 2014; 5 2012; 132 2013; 55 1992; 593 2015; 135 2019; 22 2018; 1 2015; 87 2013; 52 2009; 161 2008; 21 1979; 63 2014; 166 2008; 154 2018; 32 2018; 38 2016; 89 2007; 27 2015; 162 2017; 658 2018; 28 2015; 19 2017; 26 2008; 18 2017; 66 2017; 171 2016; 51 2007; 97 2014; 111 2016; 17 2014; 84 2018; 21 2015; 7 2014; 82 2007; 56 2014; 112 2016; 55 2012; 92 2016; 7 2018; 2018 2019; 1715 2013; 36 1993; 18 2013; 33 2005; 8 2015; 21 2016; 20 2003; 26 2018 2015; 517 2017; 19 2014 2013; 132 2000; 100 2016; 136 2014; 39 2018; 99 2010; 90 2014; 76 e_1_2_9_75_1 e_1_2_9_31_1 e_1_2_9_52_1 e_1_2_9_50_1 e_1_2_9_73_1 e_1_2_9_79_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_56_1 e_1_2_9_77_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_54_1 e_1_2_9_71_1 Jones O. (e_1_2_9_80_1) 2018 e_1_2_9_14_1 e_1_2_9_39_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_58_1 e_1_2_9_18_1 e_1_2_9_41_1 e_1_2_9_64_1 e_1_2_9_62_1 e_1_2_9_22_1 e_1_2_9_45_1 e_1_2_9_68_1 e_1_2_9_83_1 e_1_2_9_24_1 Ko M‐C (e_1_2_9_29_1) 2014 e_1_2_9_43_1 e_1_2_9_66_1 e_1_2_9_8_1 e_1_2_9_6_1 e_1_2_9_81_1 e_1_2_9_4_1 Bigliardi P. L. (e_1_2_9_28_1) 2014 George O. (e_1_2_9_20_1) 2017; 19 Luigjes J. (e_1_2_9_82_1) 2013; 55 e_1_2_9_26_1 e_1_2_9_49_1 e_1_2_9_47_1 e_1_2_9_30_1 e_1_2_9_74_1 e_1_2_9_51_1 e_1_2_9_72_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_57_1 e_1_2_9_78_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_55_1 e_1_2_9_76_1 e_1_2_9_70_1 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_59_1 e_1_2_9_19_1 e_1_2_9_42_1 e_1_2_9_63_1 e_1_2_9_40_1 e_1_2_9_61_1 e_1_2_9_21_1 e_1_2_9_46_1 e_1_2_9_67_1 e_1_2_9_23_1 e_1_2_9_44_1 e_1_2_9_65_1 e_1_2_9_7_1 e_1_2_9_5_1 Papoiu A. D. P. (e_1_2_9_2_1) 2013; 6 e_1_2_9_3_1 Ishiuji Y. (e_1_2_9_53_1) 2017; 66 Browne C. J. (e_1_2_9_60_1) 2018; 1 e_1_2_9_9_1 e_1_2_9_25_1 e_1_2_9_27_1 e_1_2_9_48_1 e_1_2_9_69_1 |
References_xml | – volume: 6 start-page: 12 issue: 8 year: 2013 publication-title: PLoS One – volume: 21 start-page: 22 year: 2008 publication-title: Dermatol Ther – start-page: 18 year: 2014 – volume: 162 start-page: 712 year: 2015 publication-title: Cell – volume: 90 start-page: 354 year: 2010 publication-title: Acta Derm Venereol – volume: 12 start-page: 448 year: 2010 publication-title: Curr Psychiatry Rep – volume: 8 start-page: 1481 year: 2005 publication-title: Nat Neurosci – volume: 135 start-page: 2814 year: 2015 publication-title: J Invest Dermatol – volume: 132 start-page: 395 year: 2013 publication-title: Drug Alcohol Depend – volume: 75 start-page: 619 year: 2016 publication-title: J Am Acad Dermatol – volume: 89 start-page: 11 year: 2016 publication-title: Neuron – volume: 8 start-page: 1725 year: 2018 publication-title: Sci Rep – volume: 112 start-page: 1729 year: 2014 publication-title: J Neurophysiol – volume: 593 start-page: 314 year: 1992 publication-title: Brain Res – volume: 55 start-page: 841 year: 2013 publication-title: Tijdschr Psychiatr – volume: 27 start-page: 14035 year: 2007 publication-title: J Neurosci – volume: 87 start-page: 124 year: 2015 publication-title: Neuron – volume: 166 start-page: 981 year: 2012 publication-title: Br J Dermatol – volume: 70 start-page: 1485 year: 2015 publication-title: Allergy – volume: 136 start-page: 879 year: 2016 publication-title: J Invest Dermatol – volume: 92 start-page: 555 year: 2012 publication-title: Acta Derm Venereol – volume: 55 start-page: 434 year: 2016 publication-title: Int J Dermatol – volume: 97 start-page: 415 year: 2007 publication-title: J Neurophysiol – volume: 21 start-page: 707 year: 2018 publication-title: Nat Neurosci – volume: 92 start-page: 295 year: 2001 publication-title: Pain – volume: 7 start-page: 160 year: 2016 publication-title: Front Psychiatry – volume: 35 start-page: 4296 year: 2015 publication-title: J Neurosci – volume: 527 start-page: 916 year: 2019 publication-title: J Comp Neurol – volume: 32 start-page: 1010 year: 2018 publication-title: J Psychopharmacol – volume: 82 start-page: 573 year: 2014 publication-title: Neuron – volume: 56 start-page: 979 year: 2007 publication-title: J Am Acad Dermatol – volume: 38 start-page: 9856 year: 2018 publication-title: J Neurosci – volume: 39 start-page: 254 year: 2014 publication-title: Neuropsychopharmacology – volume: 171 start-page: 217 year: 2017 publication-title: Cell – volume: 5 start-page: 256 year: 2014 publication-title: Front Pharmacol – volume: 22 start-page: 239 year: 2013 publication-title: Exp Dermatol – volume: 111 start-page: 488 issue: 3 year: 2014 publication-title: J Neurophysiol – volume: 36 start-page: 1241 year: 2013 publication-title: Biol Pharm Bull – volume: 99 start-page: 1274 year: 2018 publication-title: Neuron – volume: 84 start-page: 821 year: 2014 publication-title: Neuron – volume: 76 start-page: 460 year: 2014 publication-title: Neuropharmacology – volume: 45 start-page: 1313 year: 2017 publication-title: Eur J Neurosci – volume: 17 start-page: 181 year: 2016 publication-title: J Pain – volume: 108 start-page: 1 year: 2016 publication-title: Neurosci Res – volume: 9 start-page: 95 year: 2018 publication-title: Front Psychiatry – volume: 33 start-page: 643 year: 2008 publication-title: Neuropsychopharmacology – volume: 658 start-page: 91 year: 2017 publication-title: Neurosci Lett – volume: 22 start-page: 858 issue: 102 year: 2019 publication-title: Neuron – volume: 517 start-page: 284 year: 2015 publication-title: Nature – volume: 20 start-page: 8 year: 2016 publication-title: Eur J Pain – volume: 23 start-page: 1486 year: 2004 publication-title: NeuroImage – volume: 18 start-page: 203 year: 2008 publication-title: Curr Opin Neurobiol – start-page: 25 year: 2014 – volume: 1 year: 2018 publication-title: Neuropsychopharmacology – volume: 161 start-page: 1072 year: 2009 publication-title: Br J Dermatol – volume: 17368 start-page: 1625 year: 2013 publication-title: N Engl J Med – volume: 564 start-page: 258 year: 2018 publication-title: Nature – volume: 19 start-page: 217 year: 2017 publication-title: Dialogues Clin Neurosci – volume: 26 start-page: 507 year: 2003 publication-title: Trends Neurosci – volume: 154 start-page: 397 year: 2008 publication-title: Br J Pharmacol – volume: 33 start-page: 19384 year: 2013 publication-title: J Neurosci – volume: 71 start-page: 1666 year: 2016 publication-title: Allergy – volume: 24 start-page: 5000 year: 2004 publication-title: J Neurosci – volume: 26 start-page: 845 year: 2017 publication-title: Exp Dermatol – volume: 21 start-page: 927 year: 2015 publication-title: Nat Med – volume: 18 start-page: 247 year: 1993 publication-title: Brain Res Rev – volume: 7 start-page: 1259 year: 2004 publication-title: Nat Neurosci – year: 2018 publication-title: Exp Dermatol – volume: 132 start-page: 1886 year: 2012 publication-title: J Invest Dermatol – volume: 36 start-page: 10729 year: 2016 publication-title: J Neurosci – volume: 166 start-page: 93 year: 2014 publication-title: J Affect Disord – volume: 2018 start-page: 17 issue: 87 year: 2018 publication-title: Neurosci Biobehav Rev – volume: 66 start-page: 777 issue: 6 year: 2017 end-page: 782 publication-title: Arerugi. – volume: 1715 start-page: 224 year: 2019 publication-title: Brain Res – volume: 52 start-page: 58 year: 2013 publication-title: J Clin Biochem Nutr – volume: 51 start-page: 263 year: 2016 publication-title: Clin Rev Allergy Immunol – volume: 100 start-page: 861 year: 2000 publication-title: Neuroscience – volume: 28 start-page: 341 year: 2018 publication-title: Eur Neuropsychopharmacol – volume: 7 start-page: 213 year: 2015 publication-title: NeuroImage Clin – volume: 63 start-page: 7 year: 1979 publication-title: Psychopharmacology – volume: 19 start-page: 414 year: 2015 publication-title: Trends Cogn Sci – volume: 13 start-page: 1140 year: 2011 publication-title: Nicotine Tob Res – ident: e_1_2_9_11_1 doi: 10.1016/j.cell.2017.08.006 – ident: e_1_2_9_7_1 doi: 10.1016/j.neuron.2015.11.027 – ident: e_1_2_9_83_1 doi: 10.3164/jcbn.12-51 – ident: e_1_2_9_3_1 doi: 10.1038/jid.2015.223 – volume: 19 start-page: 217 year: 2017 ident: e_1_2_9_20_1 publication-title: Dialogues Clin Neurosci doi: 10.31887/DCNS.2017.19.3/gkoob – ident: e_1_2_9_55_1 doi: 10.1038/s41586-018-0740-8 – volume: 6 start-page: 12 issue: 8 year: 2013 ident: e_1_2_9_2_1 publication-title: PLoS One – ident: e_1_2_9_79_1 doi: 10.3389/fpsyt.2018.00095 – ident: e_1_2_9_49_1 doi: 10.1152/jn.00070.2006 – ident: e_1_2_9_56_1 doi: 10.1111/ijd.12864 – ident: e_1_2_9_27_1 doi: 10.3389/fphar.2014.00256 – ident: e_1_2_9_37_1 doi: 10.1523/JNEUROSCI.2966-07.2007 – ident: e_1_2_9_61_1 doi: 10.1007/BF00426913 – ident: e_1_2_9_38_1 doi: 10.1016/S0304-3959(01)00271-8 – ident: e_1_2_9_14_1 doi: 10.1038/nm.3912 – ident: e_1_2_9_47_1 doi: 10.1111/j.1529-8019.2008.00166.x – ident: e_1_2_9_57_1 doi: 10.1038/nature14188 – ident: e_1_2_9_16_1 doi: 10.1016/j.nicl.2014.12.002 – ident: e_1_2_9_31_1 doi: 10.3389/fpsyt.2016.00160 – ident: e_1_2_9_34_1 doi: 10.1038/s41598-018-19962-2 – volume: 1 year: 2018 ident: e_1_2_9_60_1 publication-title: Neuropsychopharmacology – ident: e_1_2_9_62_1 doi: 10.1016/j.neuron.2015.05.044 – ident: e_1_2_9_69_1 doi: 10.1016/j.neuron.2014.02.046 – ident: e_1_2_9_13_1 doi: 10.1007/s12016-015-8488-5 – ident: e_1_2_9_26_1 doi: 10.1016/j.neuropharm.2013.06.030 – ident: e_1_2_9_41_1 doi: 10.1523/JNEUROSCI.1979-13.2013 – ident: e_1_2_9_64_1 doi: 10.1016/j.neuron.2014.10.003 – ident: e_1_2_9_17_1 doi: 10.1152/jn.00827.2013 – ident: e_1_2_9_10_1 doi: 10.1056/NEJMcp1208814 – ident: e_1_2_9_30_1 doi: 10.1002/cne.24572 – ident: e_1_2_9_4_1 doi: 10.1016/j.neubiorev.2018.01.009 – ident: e_1_2_9_54_1 doi: 10.1111/ejn.13547 – ident: e_1_2_9_58_1 doi: 10.1523/JNEUROSCI.1267-16.2016 – volume: 55 start-page: 841 year: 2013 ident: e_1_2_9_82_1 publication-title: Tijdschr Psychiatr – ident: e_1_2_9_63_1 doi: 10.1016/j.brainres.2019.03.031 – start-page: 25 volume-title: Roles of central opioid receptor subtypes in regulating itch sensation year: 2014 ident: e_1_2_9_29_1 – ident: e_1_2_9_39_1 doi: 10.1016/j.neulet.2017.08.046 – ident: e_1_2_9_67_1 doi: 10.1016/j.neuron.2018.08.044 – ident: e_1_2_9_42_1 doi: 10.1523/JNEUROSCI.1978-13.2015 – ident: e_1_2_9_65_1 doi: 10.1038/bjp.2008.101 – ident: e_1_2_9_43_1 doi: 10.1016/j.drugalcdep.2013.02.025 – ident: e_1_2_9_22_1 doi: 10.1016/j.neures.2016.01.004 – ident: e_1_2_9_50_1 doi: 10.1038/nn1339 – ident: e_1_2_9_12_1 doi: 10.1248/bpb.b13-00319 – ident: e_1_2_9_25_1 doi: 10.1016/j.neuron.2019.03.030 – ident: e_1_2_9_44_1 doi: 10.2340/00015555-0890 – ident: e_1_2_9_52_1 doi: 10.1002/ejp.750 – start-page: 18 volume-title: Peripheral Opioids year: 2014 ident: e_1_2_9_28_1 – ident: e_1_2_9_8_1 doi: 10.1016/j.cell.2015.07.046 – volume: 66 start-page: 777 issue: 6 year: 2017 ident: e_1_2_9_53_1 publication-title: Arerugi. – ident: e_1_2_9_40_1 doi: 10.1038/sj.npp.1301438 – ident: e_1_2_9_76_1 doi: 10.1016/j.jaad.2007.01.007 – ident: e_1_2_9_33_1 doi: 10.1038/nn1579 – ident: e_1_2_9_35_1 doi: 10.1016/j.tics.2015.05.005 – ident: e_1_2_9_45_1 doi: 10.1111/exd.12070 – ident: e_1_2_9_6_1 doi: 10.1111/j.1365-2133.2012.10826.x – ident: e_1_2_9_32_1 doi: 10.1016/0006-8993(92)91327-B – ident: e_1_2_9_73_1 doi: 10.1093/ntr/ntr163 – ident: e_1_2_9_19_1 doi: 10.1016/S0166-2236(03)00233-9 – ident: e_1_2_9_5_1 doi: 10.1152/jn.00374.2013 – ident: e_1_2_9_46_1 doi: 10.1523/JNEUROSCI.0143-04.2004 – year: 2018 ident: e_1_2_9_80_1 publication-title: Exp Dermatol – ident: e_1_2_9_21_1 doi: 10.1038/npp.2013.261 – ident: e_1_2_9_48_1 doi: 10.1016/j.conb.2008.07.002 – ident: e_1_2_9_75_1 doi: 10.1038/jid.2012.52 – ident: e_1_2_9_74_1 doi: 10.1007/s11920-010-0135-5 – ident: e_1_2_9_72_1 doi: 10.1016/j.euroneuro.2018.01.007 – ident: e_1_2_9_36_1 doi: 10.1016/j.neuroimage.2004.08.023 – ident: e_1_2_9_66_1 doi: 10.1016/S0306-4522(00)00329-8 – ident: e_1_2_9_9_1 doi: 10.1111/exd.13305 – ident: e_1_2_9_81_1 doi: 10.1016/j.jaad.2016.02.1237 – ident: e_1_2_9_51_1 doi: 10.1111/all.12727 – ident: e_1_2_9_68_1 doi: 10.1038/s41593-018-0119-z – ident: e_1_2_9_77_1 doi: 10.1111/all.13065 – ident: e_1_2_9_59_1 doi: 10.1016/j.jpain.2015.10.008 – ident: e_1_2_9_24_1 doi: 10.1523/JNEUROSCI.1483-18.2018 – ident: e_1_2_9_71_1 doi: 10.1177/0269881118764991 – ident: e_1_2_9_23_1 doi: 10.1016/0165-0173(93)90013-P – ident: e_1_2_9_78_1 doi: 10.1016/j.jad.2014.04.055 – ident: e_1_2_9_70_1 doi: 10.2340/00015555-1353 – ident: e_1_2_9_18_1 doi: 10.1111/j.1365-2133.2009.09308.x – ident: e_1_2_9_15_1 doi: 10.1016/j.jid.2015.12.037 |
SSID | ssj0017375 |
Score | 2.4063346 |
SecondaryResourceType | review_article |
Snippet | Itch is a multidimensional experience involving various brain regions associated with sensory perception and emotion, as well as an urge to scratch employing... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1448 |
SubjectTerms | addiction Addictions Atopic dermatitis Circuits Cognitive ability dopamine Drug addiction Executive function itch Learning Memory Motivation Motor task performance Neostriatum Neural networks Nucleus accumbens Reinforcement reward Ventral tegmentum vicious cycle |
Title | Addiction and the itch‐scratch cycle. What do they have in common? |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fexd.14029 https://www.ncbi.nlm.nih.gov/pubmed/31482585 https://www.proquest.com/docview/2328246039 https://www.proquest.com/docview/2284562751 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA7iQbz4fqyuEsWDly5pk7YJHmRxVxZhPYjCHoSSV1GUruiuqCd_gr_RX-KkL1wfIN5aMiFpJjPzTZN8QWiPM-d5feMFLA09iHjc44wbL5ZSKBGJUGmXKPZPo94FOxmEgyl0UJ2FKfgh6h9uzjJyf-0MXKqHT0ZunwyYOQnc4T2fRo43v3NWU0f5Mc1JdomAjDmKSViyCrldPHXNyVj0DWBO4tU84BzPo8uqq8U-k5vWeKRa-uULi-M_v2UBzZVAFLeLmbOIpmy2hGb65VL7Muq0jbnODz1gmRkMOBFfg4bfX9_A0YD_vsL6GSq2sCP_xmboJJ7xlXwEuQxDB2B-H66gi-Pu-VHPK69c8DQNqfCMtowLon2eQt7n3uJYCQjqcSBTEgOYYCxg0kolU61txImk2gQ64iwVhvp0FU1nw8yuI6whl9KMkRQAA5NpxC1hWlHfKKs081kD7VeDn-iSj9xdi3GbVHkJjEqSj0oD7daidwUJx09CzUqDSWmHDwngRR6wiFAo3qmLwYLcsojM7HAMMhChQ0fW7DfQWqH5uhXqaFIho4LO5vr7vfmkO-jkDxt_F91Es4C_RLE7pommR_djuwUYZ6S288n8Aa5l9fY |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgEXXqVloYBBHHrJyokniS0hoYpttUC3B9RKe6kiv6JWRVnU7qK2J34Cv5Ffwjgv0dJKiFuijGXH45n5xo_PAG8lBs8buyjBMo0o4slIonRRrrUyKlOpsSFRnOxm4338NE2nS_CuOwvT8EP0E27BMmp_HQw8TEj_YeX-zJGd80TdgttIQCOkXqMvPXlUnIuaZpcrypmznKctr1DYx9MXvRyN_oKYlxFrHXK2H8BB19hmp8nxcDE3Q3txhcfxf__mIdxvsSjbbAbPI1jy1WO4M2lX21dgtOncUX3ugenKMYKK7IiU_OvHT_I15MIPmT2ngkMW-L-ZmwWJc3aov5NcxagFNMTfP4H97a29D-OovXUhsiIVKnLWo1TcxrKk1C-85blRFNfzRJc8JzyBmKD22ujSWp9JroV1ic0klsqJWKzCcjWr_FNgltIpi8hLwgyoy0x6jtaI2BlvLMY4gI2u9wvbUpKHmzG-Fl1qQr1S1L0ygDe96LeGh-M6ofVOhUVriqcFQUaZYMYFfX7dfyYjCisjuvKzBclQkE4DX3M8gLVG9X0tIjClUlJFja0VeHP1xdZ0VD88-3fRV3B3vDfZKXY-7n5-DvcIjqlms8w6LM9PFv4FQZ65eVmP7N8Yp_oV |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JT9wwFH5ikRAXoGXpwLS4FQcuGSWxk9jqoUIMIyiLEAJpDkiRtwhUlEHtDGI48RP4jf0lfc6mskmIWyI_y479lu_F9meADc6c5w2MF7Is8jDicY8zbrxESqFELCKlXaJ4eBTvnrGf_ag_Ad_rszAlP0Tzw81ZRuGvnYFfm-w_I7e3Bs3cD8UkTLMYkYRDRCcNd1SQ0IJl1xeYMseJH1W0Qm4bT1P1cTB6hjAfA9Yi4vTm4bzua7nR5FdnNFQdffeExvGdH7MAcxUSJVul6nyACZt_hJnDaq19EbpbxlwWpx6IzA1BoEgucYr_3j-gp0EHfkH0GCt2iGP_JmbgJMbkQt6gXE6wA6jgP5bgrLdzur3rVXcueJpGVHhGW8aFrwOeYeLn3pJECYzqSSgzP0E0wVjIpJVKZlrbmPuSahPqmLNMGBrQZZjKB7n9BERjMqUZ8zNEDExmMbc-04oGRlmlWcBasFkPfqorQnJ3L8ZVWicmOCppMSot-NaIXpcsHC8JtesZTCtD_JMiYOQhqgfF4q9NMZqQWxeRuR2MUAZDdOTYmoMWrJQz37RCHU8qplTY2WL-Xm8-3el3i4fVt4uuw8xxt5ce7B3tr8EsYjFR7pRpw9Tw98h-RrwzVF8Kvf4HMLv4xA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Addiction+and+the+itch-scratch+cycle.+What+do+they+have+in+common%3F&rft.jtitle=Experimental+dermatology&rft.au=Ishiuji%2C+Yozo&rft.date=2019-12-01&rft.eissn=1600-0625&rft.volume=28&rft.issue=12&rft.spage=1448&rft_id=info:doi/10.1111%2Fexd.14029&rft_id=info%3Apmid%2F31482585&rft.externalDocID=31482585 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0906-6705&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0906-6705&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0906-6705&client=summon |